Branford Castle-Backed Lafayette Instrument Acquires Sutter Instrument Corp.

Lafayette Instrument, LLC, a prominent global manufacturer of scientific instrumentation equipment, has acquired Sutter Instrument Corp. in a transaction that further enhances its product offerings within the life sciences sector. The deal, announced on May 12, 2026, involves an undisclosed amount and marks Lafayette's fifth bolt-on investment since being acquired by Branford Castle Partners' Fund II in 2021.

Founded over 50 years ago, Sutter Instrument is recognized as a leading provider of precision scientific instruments utilized by universities and research institutions worldwide, particularly in the fields of electrophysiology and neuroscience. The acquisition is expected to significantly bolster Lafayette's capabilities in delivering advanced tools and technologies to support life sciences research, aligning with the growing demand for innovative instrumentation in this field.

Lafayette Instrument, which specializes in manufacturing high-quality scientific equipment for various applications, including biology and medical research, aims to leverage Sutter's established product portfolio and technical expertise. This strategic acquisition underscores Lafayette's commitment to enhancing its life sciences instrumentation offerings and providing superior support to the research community. The integration of Sutter's products is anticipated to create synergies that will enhance Lafayette's competitive position in the market.

Branford Castle Partners, a private equity firm focused on lower middle-market investments, has emphasized its strategy of building a robust platform through targeted acquisitions. Ceon Francis, Managing Director at Branford Castle, noted that this acquisition not only strengthens Lafayette's market position but also broadens its product range to meet the evolving needs of life sciences customers. The firm has a long-standing history of fostering growth in its portfolio companies, particularly in niche industries such as industrials and specialty manufacturing.

The life sciences sector is experiencing significant growth, driven by advancements in research and technology. As institutions increasingly seek sophisticated tools to facilitate their studies, the integration of Sutter Instrument into Lafayette's operations is likely to enhance the company's market presence and operational capabilities. This acquisition reflects broader trends in the industry, where consolidation is becoming a key strategy for companies aiming to expand their product offerings and maintain competitiveness in a rapidly evolving landscape.